HUT51138A - Process for production of medical composition against osteoporosis containing derivatives of imidasole /1,2-a/-piridasine or pirasine - Google Patents

Process for production of medical composition against osteoporosis containing derivatives of imidasole /1,2-a/-piridasine or pirasine

Info

Publication number
HUT51138A
HUT51138A HU886708A HU670888A HUT51138A HU T51138 A HUT51138 A HU T51138A HU 886708 A HU886708 A HU 886708A HU 670888 A HU670888 A HU 670888A HU T51138 A HUT51138 A HU T51138A
Authority
HU
Hungary
Prior art keywords
piridasine
pirasine
imidasole
production
medical composition
Prior art date
Application number
HU886708A
Other languages
Hungarian (hu)
Other versions
HU203663B (en
Inventor
Ingemar Starke
Bjoern Wallmark
Kalervo Vaananen
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority claimed from PCT/SE1988/000570 external-priority patent/WO1989003844A1/en
Publication of HUT51138A publication Critical patent/HUT51138A/en
Publication of HU203663B publication Critical patent/HU203663B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU886708A 1987-10-30 1988-10-27 Process for producing pharmaceutical composition against osteoporosis containing imidazo(1,2)pyridine derivatives HU203663B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8704248A SE8704248D0 (en) 1987-10-30 1987-10-30 MEDICAL USE
PCT/SE1988/000570 WO1989003844A1 (en) 1987-10-28 1988-10-27 Hiv peptides, artificial hiv antigens and immunoassay kits

Publications (2)

Publication Number Publication Date
HUT51138A true HUT51138A (en) 1990-04-28
HU203663B HU203663B (en) 1991-09-30

Family

ID=20370069

Family Applications (1)

Application Number Title Priority Date Filing Date
HU886708A HU203663B (en) 1987-10-30 1988-10-27 Process for producing pharmaceutical composition against osteoporosis containing imidazo(1,2)pyridine derivatives

Country Status (9)

Country Link
EP (1) EP0339071A1 (en)
JP (1) JPH02501929A (en)
KR (1) KR890701587A (en)
AU (1) AU2620388A (en)
DK (1) DK322189A (en)
HU (1) HU203663B (en)
IL (1) IL88205A0 (en)
SE (1) SE8704248D0 (en)
WO (1) WO1989003833A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87988B (en) * 1987-07-16 1995-05-04 Byk Gulden Lomberg Chem Fab PROCESS FOR THE PREPARATION OF DIAZOIS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
US5081253A (en) * 1989-12-21 1992-01-14 American Home Products Corporation Imidazo(4,5-c)pyridines as antiosteoporotic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
AU5348396A (en) * 1995-05-01 1996-11-21 Fujisawa Pharmaceutical Co., Ltd. Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivati ves and their use as bone resorption inhibitors
GB9518552D0 (en) * 1995-09-11 1995-11-08 Fujisawa Pharmaceutical Co New heterocyclic compounds
WO2007028051A2 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
CA2822357A1 (en) 2010-12-22 2012-06-28 Abbvie Inc. Hepatitis c inhibitors and uses thereof
DE102012200349A1 (en) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituted fused pyrimidines and triazines and their use
US9624214B2 (en) 2012-11-05 2017-04-18 Bayer Pharma Aktiengesellschaft Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US8796305B2 (en) 2012-11-05 2014-08-05 Bayer Pharma Aktiengesellschaft Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US8778964B2 (en) 2012-11-05 2014-07-15 Bayer Pharma Aktiengesellschaft Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
US9126998B2 (en) 2012-11-05 2015-09-08 Bayer Pharma AG Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
CA2914100A1 (en) 2013-06-04 2014-12-11 Bayer Pharma Aktiengesellschaft 3-aryl-substituted imidazo[1,2-a]pyridines and the use thereof
MX2016000258A (en) 2013-07-10 2016-04-28 Bayer Pharma AG Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof.
US9688699B2 (en) 2014-02-19 2017-06-27 Bayer Pharma Aktiengesellschaft 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
CN106715426A (en) 2014-03-21 2017-05-24 拜耳医药股份有限公司 Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use
EP3137463A1 (en) 2014-05-02 2017-03-08 Bayer Pharma Aktiengesellschaft Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
EP3137465A1 (en) * 2014-05-02 2017-03-08 Bayer Pharma Aktiengesellschaft 6-chlorine-substituted imidazo[1,2-a]pyridine carboxamides and the use thereof as soluble guanylate cyclase stimulators
JP2017514899A (en) * 2014-05-02 2017-06-08 バイエル・ファルマ・アクティエンゲゼルシャフト Heterocyclyl- and heteroaryl-substituted imidazo [1,2-a] pyridines and uses thereof
EP3227286B1 (en) 2014-12-02 2018-12-26 Bayer Pharma Aktiengesellschaft Substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines and their use
JP2017536396A (en) 2014-12-02 2017-12-07 バイエル・ファルマ・アクティエンゲゼルシャフト Heteroaryl substituted imidazo [1,2-a] pyridines and uses thereof
US10150773B2 (en) 2015-02-05 2018-12-11 Bayer Pharma Aktiengesellschaft N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases
JP2018505885A (en) 2015-02-05 2018-03-01 バイエル・ファルマ・アクティエンゲゼルシャフト Substituted pyrazolo [1,5-a] -pyridine-3-carboxamide and uses thereof
WO2018184976A1 (en) 2017-04-05 2018-10-11 Bayer Pharma Aktiengesellschaft Substituted imidazo[1,2-a]pyridinecarboxamides and use of same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
DE3446778A1 (en) * 1984-12-21 1986-07-03 Dr. Karl Thomae Gmbh, 7950 Biberach NEW IMIDAZO DERIVATIVES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
DK322189D0 (en) 1989-06-28
EP0339071A1 (en) 1989-11-02
KR890701587A (en) 1989-12-21
AU2620388A (en) 1989-05-23
WO1989003833A1 (en) 1989-05-05
DK322189A (en) 1989-06-28
JPH02501929A (en) 1990-06-28
HU203663B (en) 1991-09-30
SE8704248D0 (en) 1987-10-30
IL88205A0 (en) 1989-06-30

Similar Documents

Publication Publication Date Title
HUT51138A (en) Process for production of medical composition against osteoporosis containing derivatives of imidasole /1,2-a/-piridasine or pirasine
HUT47022A (en) Process for production of medical compositions
HUT44493A (en) Process for production of new derivatives of cycloalcane (1,2-b) indol-sulphinamid and medical preparatives containing these compounds
EP0302020A3 (en) Process for the preparation of 2,2,6,6-tetramethyl-4-piperidyl-amines
HUT46912A (en) Process for production of 1,4-dihydro-piridines and medical preparatives containing such compositions
LTIP1625A (en) Process for the preparation of (1h-azol-1-ylmethyl)substituted benzotriazole derivatives
HUT51485A (en) Process for production of immune-hindering, monoquin, especially internuclein-1-hindering medical compositions
HUT42953A (en) Process for production of medical compositions
HUT48248A (en) Process for producing 3,7-diazabicyclo/3,3,1/-nonan derivatives and pharmaceutical compositions containing them
SG94591G (en) Process for preparation of (2,2)-paracyclophane
HUT50166A (en) Process for production of substituated 3,4-dihydro-rh-benzopiranes and medical compositions containing them
HUT46907A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing such substances
HU9200821D0 (en) Process for the production of medical preparation containing tioredoxine
HU896190D0 (en) Process for the preparation of pharmaceutical compositions containing pyrazole derivatives
IL82858A0 (en) Process for the preparation of 1,2,5,6,9,10-hexabromo-cyclododecane
HUT45968A (en) Process for production of derivatives of substituated amin and medical compositions containing these compounds
HUT48460A (en) Process for producing pharmaceutical compositions containing piperidinio-alkanol derivatives
HU886797D0 (en) Process for production of medical compositions against caries of bones
HUT45972A (en) Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers
IL85706A0 (en) Process for the preparation of nitroethene derivatives
IL86646A (en) Process for the preparation of 5,11-di-and 5,6,11,12-tetraphenylnaphthacenes
HUT38636A (en) Process for production of derivatives of imidazo /1,2-a/ kynoline and medical preparatives containing there of
HUT50180A (en) Process for production of derivatives of 2,3,4,5,6,7-hexahydro-2,7-methan-1,5-benzoxasonine or 1,4-benzoxasonine and medical compositions containing them
EP0297496A3 (en) Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
HU885893D0 (en) Process for the preparation of substituted azaciclohexyl derivatives

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee